FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileLunai Bioworks Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
LNAI
Lunai Bioworks Inc. Stock AnalysisComprehensive stock analysis for Lunai Bioworks Inc. (LNAI) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisLNAI
LNAI
Lunai Bioworks Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
LNAI
Home🔹Stocks🔹Lunai Bioworks Inc.

Lunai Bioworks Inc.

🇺🇸LNAI•NASDAQ

Lunai Bioworks Inc.

🇺🇸LNAI•NASDAQ
Market cap
$829.68K
Sentiment

Your view on LNAI

Mkt Cap
$829.68K
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Lunai Bioworks Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
David H. Weinstein
Headquarters
US
Industry
Biotechnology
Sector
Healthcare
CEO
David H. Weinstein
Headquarters
US
Description

A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

Fair value for Lunai Bioworks Inc. from FRC's valuation model, read against the market price. LNAI last traded at $0.16; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Lunai Bioworks Inc.. Starting points for Lunai Bioworks Inc.: EPS -$0.77, beta 0.35 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Lunai Bioworks Inc.. Lunai Bioworks Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Lunai Bioworks Inc.. Trailing twelve-month EPS for Lunai Bioworks Inc. stands at -$0.77. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Lunai Bioworks Inc.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Lunai Bioworks Inc. valued side by side against its closest peers. Lunai Bioworks Inc. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

News

Latest headlines and market coverage.

Latest headlines and company announcements for Lunai Bioworks Inc.. Coverage tracks Lunai Bioworks Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Lunai Bioworks Inc.

Peer companies

  • ANLAdlai Nortye Ltd. American Depositary Shares
  • APLMApollomics, Inc.
  • BLRXBioLineRx Ltd.
  • ERNAErnexa Therapeutics Inc.
  • GOVXGeoVax Labs, Inc.
  • ICUSeaStar Medical Holding Corporation
  • LPCNLipocine Inc.

More Biotechnology companies

  • ENGNWenGene Holdings Inc. Warrants
  • ENLVEnlivex Therapeutics Ltd.
  • ENP.AXEntropy Neurodynamics Limited
  • ENSCEnsysce Biosciences, Inc.
  • ENTAEnanta Pharmaceuticals, Inc.
  • ENTXEntera Bio Ltd.
  • ENVBEnveric Biosciences, Inc.
  • ENZCEnzolytics Inc.
  • ENZNEnzon Pharmaceuticals, Inc.
  • EPRXEupraxia Pharmaceuticals Inc.
  • EPRX.TOEupraxia Pharmaceuticals Inc.
  • EQEquillium, Inc.

ETFs holding Lunai Bioworks Inc.

Largest holders, then the funds most concentrated in LNAI · % = share of the fund

  • VXFVanguard Extended Market ETF0.00%
LNAI Analysis
Fair
Past1
Growth2
Health5
Profit1
Value1

News

Latest Market News